BioMarin, as expected, sees delay to FDA review of hemophilia gene therapy
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Discover how our cutting-edge technology delivers unrivaled predictive insights for health plans, payers, underwriters, and more.
Discover how our cutting-edge technology delivers unrivaled predictive insights for health plans, payers, underwriters, and more.
Discover how our cutting-edge technology delivers unrivaled predictive insights for health plans, payers, underwriters, and more.
Discover how our cutting-edge technology delivers unrivaled predictive insights for health plans, payers, underwriters, and more.
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)